World's Best Scientists 2026 revealed!
Michael A.S. Jewett

Michael A.S. Jewett

D-Index & Metrics

Medicine

D-Index
96
Citations
29740
World Ranking
9777
National Ranking
391

Overview

Michael A.S. Jewett is affiliated with the University of Toronto in Canada and has contributed extensively to the field of medicine, with a particular focus on surgery, pulmonary and respiratory medicine, molecular biology, oncology, and public health.

The primary areas of research for Jewett include renal cell carcinoma treatment, bladder and urothelial cancer treatments, testicular diseases and treatments, renal and related cancers, urinary and genital oncology studies, sarcoma diagnosis and treatment, and economic and financial impacts of cancer.

Jewett has published in various reputable journals, including:

  • British Journal of Urology (13 publications)
  • The Journal of Urology (12 publications)
  • Journal of Clinical Oncology (10 publications)
  • Canadian Urological Association Journal (8 publications)
  • European Urology (6 publications)

Frequent co-authors throughout Jewett's research career include:

  • Robert J. Hamilton (18 coauthored papers)
  • Antonio Finelli (15 coauthored papers)
  • Girish S. Kulkarni (14 coauthored papers)
  • Lynn Anson-Cartwright (14 coauthored papers)
  • Peter Chung (13 coauthored papers)

Highlights among recent papers include:

  • "Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis," published in 2023 in The Lancet Oncology
  • "Small Renal Mass Surveillance: Histology-specific Growth Rates in a Biopsy-characterized Cohort," published in 2020 in European Urology
  • "FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?†," published in 2020 in European Urology
  • "Utility of Serum miR-371a-3p in Predicting Relapse on Surveillance in Patients with Clinical Stage I Testicular Germ Cell Cancer," published in 2020 in European Urology Oncology
  • "Predicting Disease Recurrence, Early Progression, and Overall Survival Following Surgical Resection for High-risk Localized and Locally Advanced Renal Cell Carcinoma," published in 2021 in European Urology

Jewett's work mainly explores surgical approaches and oncological treatments related to urinary tract cancers, particularly bladder and renal cancers, as well as testicular disease monitoring. The research spans clinical outcomes, biomarker utility, and disease surveillance strategies, indicating a comprehensive approach to oncological surgery and treatment modalities.

Best Publications

  • European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I

    Susanne Krege;Jörg Beyer;Rainer Souchon;Peter Albers

  • Adjuvant Sunitinib or Sorafenib for High-Risk, Non-Metastatic Renal-Cell Carcinoma (ECOG-ACRIN E2805): A Double-Blind, Placebo-Controlled, Randomised, Phase 3 Trial

    Naomi B. Haas;Judith Manola;Robert G. Uzzo;Keith T. Flaherty

  • Active Surveillance of Small Renal Masses: Progression Patterns of Early Stage Kidney Cancer ☆

    Michael A.S. Jewett;Kamal Mattar;Joan Basiuk;Christopher G. Morash

  • Clinical practice. Small renal mass.

    Inderbir S. Gill;Monish Aron;Debra A. Gervais;Michael A.S. Jewett

  • Testicular germ cell tumours

    Ewa Rajpert-De Meyts;Katherine A McGlynn;Keisei Okamoto;Michael A S Jewett

  • Comparison of immediate vs deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma receiving sunitinib: The surtime randomized clinical trial

    Axel Bex;Peter Mulders;Michael A.S. Jewett;John Wagstaff

  • Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis.

    Marc C. Smaldone;Alexander Kutikov;Brian L. Egleston;Daniel J. Canter

  • Techniques, Safety and Accuracy of Sampling of Renal Tumors by Fine Needle Aspiration and Core Biopsy

    Alessandro Volpe;John R. Kachura;William R. Geddie;Andrew J. Evans

  • Patterns of Relapse in Patients With Clinical Stage I Testicular Cancer Managed With Active Surveillance

    Christian Kollmannsberger;Torgrim Tandstad;Philippe L. Bedard;Gabriella Cohn-Cedermark

  • VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail

    Andrew J. Evans;Ryan C. Russell;Olga Roche;T. Nadine Burry

  • Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline

    Antonio Finelli;Nofisat Ismaila;Bill Bro;Jeremy Durack

  • Treatment of Localised Renal Cell Carcinoma

    Hendrik Van Poppel;Frank Becker;Jeffrey A Cadeddu;Inderbir S Gill

  • ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up

    F Honecker;J Aparicio;D Berney;Jörg Beyer

  • Contemporary Results of Percutaneous Biopsy of 100 Small Renal Masses: A Single Center Experience

    Alessandro Volpe;Kamal Mattar;Antonio Finelli;John R. Kachura

  • Propensity score analysis of radical cystectomy versus bladder-sparing trimodal therapy in the setting of a multidisciplinary bladder cancer clinic

    Girish S Kulkarni;Thomas Hermanns;Yanliang Wei;Bimal Bhindi

  • The Uncertainty Of Radio Frequency Treatment Of Renal Cell Carcinoma: Findings At Immediate And Delayed Nephrectomy

    Ricardo A. Rendon;John R. Kachura;Joan M. Sweet;Mark R. Gertner

  • Rationale for percutaneous biopsy and histologic characterisation of renal tumours.

    Alessandro Volpe;Antonio Finelli;Inderbir S. Gill;Michael A.S. Jewett

  • Retroperitoneal Lymphadenectomy for Testis Tumor with Nerve Sparing for Ejaculation

    Michael A.S. Jewett;Young-Soo P. Kong;Susan D. Goldberg;Jeremy F.G. Sturgeon

  • Radical Radiotherapy for Muscle Invasive Transitional Cell Carcinoma of the Bladder: Failure Analysis

    Mary K. Gospodarowicz;N.V. Hawkins;G.A. Rawlings;J.G. Connolly

  • The Y deletion gr/gr and susceptibility to testicular germ cell tumor

    Katherine L. Nathanson;Peter A. Kanetsky;Rachel Hawes;David J. Vaughn

Frequent Co-Authors

Neil Fleshner
Neil Fleshner Princess Margaret Cancer Centre
Antonio Finelli
Antonio Finelli University Health Network
Alexandre R. Zlotta
Alexandre R. Zlotta University Health Network
Padraig Warde
Padraig Warde Princess Margaret Cancer Centre
John Trachtenberg
John Trachtenberg University of Toronto
George M. Yousef
George M. Yousef University of Toronto
Mary K. Gospodarowicz
Mary K. Gospodarowicz Princess Margaret Cancer Centre
Malcolm J. Moore
Malcolm J. Moore Princess Margaret Cancer Centre
Andrew Evans
Andrew Evans University of Dundee
Steven A. Narod
Steven A. Narod University of Toronto

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Medicine doesn’t always mean becoming a doctor. There are several rewarding roles in healthcare that can be accessed with flexible, online degrees. These programs make it easier for students to balance work, family, and education, while often saving on tuition costs.

If you’re interested in the business side of healthcare, healthcare administration degrees provide training in leadership, policy, and management. For those aiming higher, the cheapest online mha programs offer a graduate-level pathway to top administrative positions.

For nursing professionals, advancing your career is possible with the most affordable online dnp programs, designed for nurses aiming for leadership or advanced clinical practice. Pharmacists can also move forward with a 3-year online pharmd, ideal for those seeking a quicker, cost-effective route to a doctorate.

Online programs in healthcare are evolving, providing accessible, respected avenues for students to achieve their career goals within the healthcare sector.

Best Scientists Citing Michael A.S. Jewett

Trending Scientists